Georgiana Surpateanu
Affiliations: | 2009-2013 | ICSN | CNRS, Paris, Île-de-France, France |
Google:
"Georgiana Surpateanu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mounkoro P, Michel T, Benhachemi R, et al. (2018) Mitochondrial complex III Q -site inhibitor resistance mutations found in laboratory selected mutants and field isolates. Pest Management Science |
| Nguyen TL, Nokin MJ, Egorov M, et al. (2018) mTOR inhibition via displacement of phosphatidic acid induces enhanced cytotoxicity specifically in cancer cells. Cancer Research |
| de Miguel L, Noiray M, Surpateanu G, et al. (2014) Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting. International Journal of Pharmaceutics. 460: 73-82 |
| Nguyen TB, Lozach O, Surpateanu G, et al. (2012) Synthesis, biological evaluation, and molecular modeling of natural and unnatural flavonoidal alkaloids, inhibitors of kinases. Journal of Medicinal Chemistry. 55: 2811-9 |
| Surpateanu G, Iorga BI. (2012) Evaluation of docking performance in a blinded virtual screening of fragment-like trypsin inhibitors. Journal of Computer-Aided Molecular Design. 26: 595-601 |
| Surpateanu G, Soulé JF, Beau JM, et al. (2012) Conformational study of glycal-type neuraminidase inhibitors Journal of Carbohydrate Chemistry. 31: 114-129 |
| Goeminne A, Berg M, McNaughton M, et al. (2008) N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase. Bioorganic & Medicinal Chemistry. 16: 6752-63 |
| Goeminne A, McNaughton M, Bal G, et al. (2008) Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors. European Journal of Medicinal Chemistry. 43: 315-26 |
| Joossens J, Ali OM, El-Sayed I, et al. (2007) Small, potent, and selective diaryl phosphonate inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties. Journal of Medicinal Chemistry. 50: 6638-46 |
| Goeminne A, McNaughton M, Bal G, et al. (2007) 1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 2523-6 |